Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.

By R. Dworkin, M. Backonja, M. Rowbotham, Robert R. Allen, C. Argoff, G. Bennett, M. Bushnell, John T. Farrar, B. Galer, J. Haythornthwaite and 12 more. Archives of Neurology, 2003

1,295 citations recorded by the source corpus.

Subfields: Pharmacology, Physiology, Surgery

View Paper: https://www.semanticscholar.org/paper/02b0e7e38f40f96e5169ed9c524372f2cd6436b1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pharmacology

In Physiology

In Surgery

Citations in the corpus

EFNS guidelines on pharmacological treatment of neuropathic pain (2006, background): “Therefore caution is recommended for older patients, particularly those with cardiovascular risk factors [1,14].”
Pharmacotherapy for neuropathic pain in adults: systematic review, meta-analysis and updated NeuPSIG recommendations (2015, background): “…et al (2008) PHN, pregabalin 300 mg and 600 mg, van Seventer et al (2006) PHN, pregabalin 300 mg, Sabatowski et al (2004) PHN, pregabalin 600 mg, Dworkin et al (2003) PPN, pregabalin 300 mg, Smith et al (2013) PPN, pregabalin 300 mg, Rauck et al (2012) PPN, pregabalin 300 mg and 600 mg, Satoh…”
Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) (2005, background): “Clinically, neuropathic pain is generally characterized by the association of unspecified positive and negative sensory symptoms, but there are still no consensus diagnostic criteria of neuropathic pain (Dworkin et al., 2003; Hansson, 2002; Jensen et al., 2001; Woolf and Mannion, 1999).”
Neuropathic Pain (2009, background): “Nociceptive pain is an alarm mediated by highthreshold unmyelinated C or thinly myelinated Aδ primary sensory neurons that feed into nociceptive pathways of the central nervous system (CNS) (Woolf & Ma 2007).”
Pharmacologic management of neuropathic pain: Evidence‐based recommendations (2007, positive): “Evidence-based consensus treatment recommendations exist [25], but additional medications have become available since their publication [31].”
Recommendations for the management of herpes zoster. (2007, methodology): “mended to assess cardiac conduction abnormalities before beginning TCA treatment of patients 140 years of age who have neuropathic pain [162].”
Algorithm for neuropathic pain treatment: An evidence based proposal (2005, positive): “Evidence-based consensus treatment recommendations exist [25], but additional medications have become available since their publication [31].”
Evaluation and management of peripheral nerve injury. (2008, background): “…requires medications which are specific for neuropathic pain, such as tricyclic antidepressants, serotonin reuptake inhibitors, anti-convulsants such as carbamazepine, phenytoin, and lamotrigine, gabapentin and pregabalin, antiarrhythymics, baclofen and others (Dworkin et al., 2003; Kingery, 1997).”
Prevalence of chronic pain with neuropathic characteristics in the general population (2008, neutral): “It is generally chronic and disabling, and is among the most challenging to treat (Dworkin et al., 2003; Finnerup et al., 2005; Attal et al., 2006).”
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values (2006, background): “It was our rationale to examine both cutaneous and deep pain sensitivity in order to create profiles of sensory signs related to underlying mechanisms (Price and Dubner, 1977; Devor, 1991; Bennett, 1994; Bendtsen et al., 1996; Fields et al., 1998; Baumgärtner et al., 2002; Hansson, 2002; Treede et a”
Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome (2007, background): “The most common location of chronic neuropathic pain is the back and legs (Dworkin et al., 2003), and 10–40% of patients who have undergone lumbosacral spine surgery to alleviate neuropathic radicular pain instead experience persistent or recurrent pain (Wilkinson, 1991; North et al., 1993).”
Quantitative sensory testing: a comprehensive protocol for clinical trials (2006, methodology): “…to assess all aspects of somatosensory function that may be of clinical interest (Arendt-Nielsen, 1997; Arezzo et al., 1993; Cruccu et al., 2004; Dworkin et al., 2003; Dyck et al., 1993a,b; Fields et al., 1998; Gescheider et al., 2001; Gracely et al., 2003; Hansson and Lindblom, 1993; Shy et…”